Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CALML3 | P27482 | 7/20 | 0.52 |
| ▸ | MAOB | P27338 | 6/20 | 0.50 |
| ▸ | MAOA | P21397 | 6/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.42 |
| ▸ | SDHA | P31040 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1769446 | 0.91 | MAOB (0.43) | CALML3MAOBMAOALMNAPTGS1 | |
| SCHEMBL6679441 | 0.87 | CALML3 (0.51) | CALML3MAOBMAOACYP2C19CYP3A4 | |
| SCHEMBL6679438 | 0.87 | CALML3 (0.51) | CALML3MAOBMAOACYP2C19CYP3A4 | |
| SCHEMBL1769325 | 0.86 | CALML3 (0.40) | CALML3MAOBMAOACYP3A4LMNA | |
| SCHEMBL1769464 | 0.84 | MAOA (0.51) | MAOBMAOA | |
| SCHEMBL1769322 | 0.82 | F10 (0.67) | — | |
| SCHEMBL1222791 | 0.81 | CALML3 (0.67) | CALML3MAOBMAOACYP2C19CYP3A4 | |
| SCHEMBL10033715 | 0.81 | CALML3 (0.67) | CALML3MAOBMAOACYP2C19CYP3A4 | |
| SCHEMBL1222787 | 0.81 | CALML3 (0.67) | CALML3MAOBMAOACYP2C19CYP3A4 | |
| SCHEMBL6608194 | 0.79 | CALML3 (0.43) | CALML3MAOBMAOALMNAPTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011061760-A1 | NOVEL ANTITHROMBOTIC AGENTS | CADILA HEALTHCARE LIMITED (IN) | 2011-05-26 | — | — | WO | disclosed |